Spark Investment Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-10,800
Closed -$61K 688
2018
Q3
$61K Hold
10,800
﹤0.01% 626
2018
Q2
$66K Hold
10,800
﹤0.01% 623
2018
Q1
$72K Sell
10,800
-2,400
-18% -$16.5K ﹤0.01% 568
2017
Q4
$97K Sell
13,200
-1,700
-11% -$12.5K 0.01% 623
2017
Q3
$105K Sell
14,900
-5,400
-27% -$37.3K 0.01% 661
2017
Q2
$142K Sell
20,300
-2,300
-10% -$15.2K 0.01% 694
2017
Q1
$156K Hold
22,600
0.01% 741
2016
Q4
$124K Buy
22,600
+2,600
+13% +$13.6K 0.01% 698
2016
Q3
$100K Sell
20,000
-13,900
-41% -$65.4K 0.01% 751
2016
Q2
$152K Sell
33,900
-12,700
-27% -$58.2K 0.01% 661
2016
Q1
$209K Sell
46,600
-4,300
-8% -$20.5K 0.02% 609
2015
Q4
$267K Buy
50,900
+6,500
+15% +$37K 0.03% 509
2015
Q3
$254K Hold
44,400
0.03% 500
2015
Q2
$316K Hold
44,400
0.04% 435
2015
Q1
$295K Buy
44,400
+14,100
+47% +$88K 0.04% 467
2014
Q4
$181K Buy
30,300
+3,900
+15% +$20K 0.03% 504
2014
Q3
$129K Sell
26,400
-1,200
-4% -$5.81K 0.02% 563
2014
Q2
$124K Sell
27,600
-3,200
-10% -$14.3K 0.02% 545
2014
Q1
$135K Buy
30,800
+9,600
+45% +$45.7K 0.02% 583
2013
Q4
$108K Buy
21,200
+1,000
+5% +$4.88K 0.02% 556
2013
Q3
$91K Sell
20,200
-18,500
-48% -$92.1K 0.02% 515
2013
Q2
$196K Buy
+38,700
New +$193K 0.05% 341

Other funds holding CPIX

Spark Investment Management's CPIX Position: Q4 2018 in Review

Spark Investment Management sold out of Cumberland Pharmaceuticals (CPIX) in Q4 2018, closing a stake of 10,800 shares — an estimated $61K sold.

Spark Investment Management first reported a position in CPIX in Q2 2013 and held it in 22 quarters. The position peaked at $316K in Q2 2015. 27 funds tracked by Wall St. Rank hold CPIX as of Q4 2018.

  • Spark Investment Management reported no remaining Cumberland Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Spark Investment Management sold 10,800 Cumberland Pharmaceuticals shares in Q4 2018, an estimated $61K.
  • Spark Investment Management first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 22 quarters.
  • Spark Investment Management's Cumberland Pharmaceuticals position peaked at $316K in Q2 2015.
  • 27 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2018.

Based on Spark Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.